GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » EBITDA Margin %

Greenbrook TMS (Greenbrook TMS) EBITDA Margin % : -55.56% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Greenbrook TMS's EBITDA for the three months ended in Mar. 2024 was $-10.01 Mil. Greenbrook TMS's Revenue for the three months ended in Mar. 2024 was $18.01 Mil. Therefore, Greenbrook TMS's EBITDA margin for the quarter that ended in Mar. 2024 was -55.56%.


Greenbrook TMS EBITDA Margin % Historical Data

The historical data trend for Greenbrook TMS's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS EBITDA Margin % Chart

Greenbrook TMS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only -27.67 -49.68 -26.25 -115.91 -46.67

Greenbrook TMS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.19 -31.88 -36.07 -81.71 -55.56

Competitive Comparison of Greenbrook TMS's EBITDA Margin %

For the Medical Care Facilities subindustry, Greenbrook TMS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenbrook TMS's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Greenbrook TMS's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Greenbrook TMS's EBITDA Margin % falls into.



Greenbrook TMS EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Greenbrook TMS's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-34.437/73.787
=-46.67 %

Greenbrook TMS's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-10.008/18.012
=-55.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenbrook TMS  (OTCPK:GBNHF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Greenbrook TMS EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenbrook TMS (Greenbrook TMS) Business Description

Traded in Other Exchanges
N/A
Address
890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4
Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.

Greenbrook TMS (Greenbrook TMS) Headlines